GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (BUE:AZN) » Definitions » Inventories, Other

AstraZeneca (BUE:AZN) Inventories, Other : ARS0 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is AstraZeneca Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. AstraZeneca's other inventories for the quarter that ended in Dec. 2024 was ARS0 Mil.

AstraZeneca's quarterly other inventories increased from Jun. 2024 (ARS5,074,798 Mil) to Sep. 2024 (ARS5,381,731 Mil) but then declined from Sep. 2024 (ARS5,381,731 Mil) to Dec. 2024 (ARS0 Mil).

AstraZeneca's annual other inventories declined from Dec. 2022 (ARS0 Mil) to Dec. 2023 (ARS-0 Mil) but then increased from Dec. 2023 (ARS-0 Mil) to Dec. 2024 (ARS0 Mil).


AstraZeneca Inventories, Other Historical Data

The historical data trend for AstraZeneca's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Inventories, Other Chart

AstraZeneca Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AstraZeneca Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4,496,422.58 5,074,798.43 5,381,730.76 -

AstraZeneca Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


AstraZeneca Business Description

Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.